Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Assertio Therapeutics Inc. logo

Assertio Therapeutics Inc.

Sector: Healthcare   

Industry: Drug Manufacturers - Specialty & Generic

Optionable: Yes  Market Cap: 102734573.0  90-day average vol: 809706.0

Previous close: 1.04  Open: 1.02  Bid: 1.01  Ask: 1.07
52 week range    
Last updated: Sunday 16th June 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord


ASRT Income Statement

Invalid dateDec-20Dec-21Dec-22Dec-23
Amortization of intangibles25 M28 M33 M28 M
Basic EPS from continuing operations-0.032.33-4.67
Basic EPS total-1.08-0.032.33-4.67
Basic weighted shares outstanding26 M43 M47 M71 M
Cost of sales-20 M16 M19 M27 M
Depreciation-2 M1000000.0800000.0700000.0
Depreciation unreconciled25 M28 M33 M28 M
DepreciationAndAmortization25 M28 M33 M28 M
Diluted EPS total-1.08-0.032.03-4.67
Diluted normalized net income/share-0.032.03-4.67
Diluted weighted shares outstanding26 M43 M55 M71 M
GainOnSaleOfPPE112 M
GeneralAndAdministrativeExpense53 M47 M79 M
Gross operating profit86 M95 M137 M125 M
ImpairmentOfCapitalAssets17 M
Income before tax-46 M-553000.031 M-254 M
Income restructuring and M&A18 M1 M5 M
Income taxes-17 M728000.0-78 M78 M
Interest income2 M
InterestExpenseNonOperating16 M10 M8 M13 M
MiscOtherSpecialCharges-59 M243000.0-278000.03 M
Net income from total operations-28 M-1 M110 M-332 M
NetIncomeCommonStockholders-28 M-1 M110 M-332 M
NetIncomeContinuousOperations-28 M-1 M110 M-332 M
NetNonOperatingInterestIncomeExpense-16 M-10 M-8 M-13 M
Normalized income59 M
Operating income-47 M9 M39 M-244 M
Operating income before depreciation (EBITDA)3 M39 M73 M-212 M
OperatingExpense133 M81 M79 M109 M
Other income net-53 M4 M19 M251 M
OtherGandA53 M47 M79 M
OtherImpairmentOfCapitalAssets280 M
OtherOperatingExpenses-3 M
PromotionAndAdvertising-400000.02 M3 M4 M
Research & development expense4 M3 M
ResearchExpense4 M3 M
RestructringAndMnAIncome18 M1 M5 M
Revenue per share25 M28 M33 M28 M
SalariesAndWages-11 M-500000.0-1 M
Selling Gen & administrative expense104 M53 M47 M79 M
SellingAndMarketingExpense104 M2 M3 M4 M
SellingExpense104 M
Special income/charges-35 M-1 M-5 M
Total Income available for interest expense (EBIT)-30 M10 M39 M-241 M
Total common shares outstanding43 M45 M56 M95 M
Total net income-28 M-1 M110 M-332 M
Total ordinary shares95 M95 M95 M95 M
Total revenues106 M111 M156 M152 M
TotalExpenses113 M97 M98 M136 M
TotalRevenue106 M111 M156 M152 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu


I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.


Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University